Skip to content
DraconiticResearch
Search Sources API
182,460 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY 4.0BMJ Open

Does a digital support intervention reduce sedentary behaviour during cancer treatment in individuals with breast, prostate or colorectal cancer? Study protocol for a Swedish multicentre randomised controlled trial

  1. 1Department of Health Sciences, Innovation and Design, Mälardalen University, Västerås, Sweden
  2. 2Centre for Welfare Change, Department of Health Sciences, Innovation and Design, Mälardalen University, Västerås, Sweden
  3. 3Department of Women’s and Children’s Health, Uppsala university, Uppsala, Sweden

Abstract

Introduction: Sedentary behaviour increases during cancer treatment, often because of side effects from treatment. However, evidence on interventions specifically targeting sedentary behaviour during active cancer treatment is limited. Therefore, the aims of the reduce sedentary behaviour during cancer treatment (RedSedCan) study are to investigate the effects of sedentary behaviour on health outcomes and to explore the economic, environmental and social sustainability perspectives of a digital support intervention for reducing sedentary behaviour in individuals with breast, prostate or colorectal cancer receiving neoadjuvant or adjuvant cancer treatment. In addition, participants’ experiences with the intervention as well as healthcare professionals’ perspectives for supporting individuals with cancer to reduce sedentary behaviour will be explored.

Methods and analysis: A multicentre randomised controlled trial will be conducted with short-term (3 months) and long-term (6, 12 and 24 months) follow-up. After baseline assessments, participants will be randomised into one of two groups as follows: a digital support intervention group or a control group receiving usual care. The digital support intervention—the RedSedCan intervention—consists of access to a home page containing information and tips about how to reduce sedentary behaviour, a commercially available step-counting mobile application, use of mobile phone reminder/alarm functions and four digital meetings with physiotherapists. During these meetings, participants will receive support for setting and reviewing goals. The main outcome is time spent engaging in sedentary behaviour, which is measured with a thigh-worn accelerometer at 3 months. Secondary outcomes include long-term follow-ups, physical activity, health-related outcomes, health economic effects and greenhouse gas emissions from interventions and healthcare. In addition, the experiences of participants undergoing the intervention and the attitudes and perceived barriers and facilitating factors of healthcare professionals for supporting individuals with cancer to reduce sedentary behaviour will be explored qualitatively.

Ethics and dissemination: Ethical approval has been obtained from the appropriate ethics review authority. Findings will be disseminated through peer-reviewed publications, conference presentations and other relevant scientific and patient communities.

Trial registration number: NCT06719206.

Related

  1. Behavioural intervention and guided stepping training early post-stroke (BIG STEPS): protocol for a multicentre randomised controlled trial.
    Charmaine van Eeden, Aiza Khan, Wendimagegn Alemayehu +11
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref
  2. Lifestyle intervention to improve outcomes in dichorionic twin pregnancies: study protocol for a multicentre randomised controlled trial with an integrated pilot study – the LIFETWIN trial
    Katleen Lodewyckx, Yael Winter Shafran, Birgit Coucke +8
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsCrossrefDOAJPMC
  3. Implementation of a complex intervention for hip fracture care: a protocol for an embedded mixed-methods process evaluation of a multicentre cluster randomised trial in India, Nepal, the Philippines, Thailand and Vietnam.
    Elizabeth Armstrong, Rebecca Ivers, Thuy Anh Bui +20
    BMJ openPeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  4. Comparison of ‘quilting sutures’ with ‘conventional sutures and drain placement’ after mastectomy: protocol for the BE-Quilt – a multicentre, pragmatic randomised controlled trial
    Suzanna De Winter, Anaïs Brouckaert, Kathleen Lambein +5
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  5. Immobilisation versus early active motion following primary flexor pollicis longus tendon zones 1-2 repair: protocol for a registry-based multicentre randomised controlled trial in Sweden.
    Maria Wilcke, Annika Elmstedt, Erika Nyman +5
    BMJ openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
BibTeX
@article{radman2026does,
  title = {{Does a digital support intervention reduce sedentary behaviour during cancer treatment in individuals with breast, prostate or colorectal cancer? Study protocol for a Swedish multicentre randomised controlled trial}},
  author = {Lisa Rådman and Johanna Zetterlund and Petra von Heideken Wågert and Anna Henriksson},
  journal = {BMJ Open},
  year = {2026},
  month = oct,
  doi = {10.1136/bmjopen-2026-125120},
  url = {https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-125120},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Does a digital support intervention reduce sedentary behaviour during cancer treatment in individuals with breast, prostate or colorectal cancer? Study protocol for a Swedish multicentre randomised controlled trial
AU  - Lisa Rådman
AU  - Johanna Zetterlund
AU  - Petra von Heideken Wågert
AU  - Anna Henriksson
PY  - 2026
DA  - 2026/10/29
JO  - BMJ Open
DO  - 10.1136/bmjopen-2026-125120
UR  - https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-125120
AB  - Introduction: Sedentary behaviour increases during cancer treatment, often because of side effects from treatment. However, evidence on interventions specifically targeting sedentary behaviour during active cancer treatment is limited. Therefore, the aims of the reduce sedentary behaviour during cancer treatment (RedSedCan) study are to investigate the effects of sedentary behaviour on health outcomes and to explore the economic, environmental and social sustainability perspectives of a digital support intervention for reducing sedentary behaviour in individuals with breast, prostate or colorectal cancer receiving neoadjuvant or adjuvant cancer treatment. In addition, participants’ experiences with the intervention as well as healthcare professionals’ perspectives for supporting individuals with cancer to reduce sedentary behaviour will be explored.  Methods and analysis: A multicentre randomised controlled trial will be conducted with short-term (3 months) and long-term (6, 12 and 24 months) follow-up. After baseline assessments, participants will be randomised into one of two groups as follows: a digital support intervention group or a control group receiving usual care. The digital support intervention—the RedSedCan intervention—consists of access to a home page containing information and tips about how to reduce sedentary behaviour, a commercially available step-counting mobile application, use of mobile phone reminder/alarm functions and four digital meetings with physiotherapists. During these meetings, participants will receive support for setting and reviewing goals. The main outcome is time spent engaging in sedentary behaviour, which is measured with a thigh-worn accelerometer at 3 months. Secondary outcomes include long-term follow-ups, physical activity, health-related outcomes, health economic effects and greenhouse gas emissions from interventions and healthcare. In addition, the experiences of participants undergoing the intervention and the attitudes and perceived barriers and facilitating factors of healthcare professionals for supporting individuals with cancer to reduce sedentary behaviour will be explored qualitatively.  Ethics and dissemination: Ethical approval has been obtained from the appropriate ethics review authority. Findings will be disseminated through peer-reviewed publications, conference presentations and other relevant scientific and patient communities.  Trial registration number: NCT06719206.
SN  - 2044-6055
SN  - 2044-6055
ER  -